proton therapy treatment room

Benefits of proton therapy

Proton therapy is the most advanced and precise type of radiation treatment for many types of cancers.

It is also one of the most promising cancer therapies ever developed.1,2 With minimal radiation exposure of healthy tissues compared to other cancer treatments,3-6 proton therapy potentially reduces the risk of secondary cancers and improves the patients' quality of life. Today, 20%* of radiation therapy patients could benefit from proton therapy, and improve their well-being and often outcome.7-9

* Source: Alcimed study, "Understand, quantify and improve patients' access to Proton Therapy in the USA and Europe", November 2017

Photon-based Radiotherapy
proton-based-radiotherapy.jpg
Proton Therapy
Proton Therapy

What are the benefits of proton therapy?

Minimizes radiation exposure of healthy tissues.

Lower integral dose per treatment.10-12

May improve the patients' quality of life.13-15

Potentially reduces the risk of secondary cancers.16-18

Widens the possibility of retreatment and reradiation for patients with recurring forms of cancer.19-21

Medical Indications

Proton therapy is considered to be the most advanced radiation treatment for many forms of cancer. About 20%* of radiotherapy patients could benefit from it and it is already used to treat multiple forms of cancers. It is particularly appropriate when treatment options are limited or present unacceptable risks and short to long-term side effects to the patient.22

* Source: Alcimed study, "Understand, quantify and improve patients' access to Proton Therapy in the USA and Europe", November 2017

Discover the different types of cancers for which proton therapy can be a valid treatment option

IBA Proton Therapy centers worldwide

We have developed customized, made-to-measure, proton therapy solutions for more than 60 leading medical centers across the world.

Discover the centers where you can get access to IBA Proton Therapy technology.

What they say about it

Steve and Valerie, parents of Viggo

treated at Proton Therapy center

Start a treatment

Who is eligible?

Your proton therapy community

Campus is the most knowledgeable proton therapy community in the world. With Campus, physicians, medical physicists, dosimetrists, therapists, managers and industry partners will have the tools to share knowledge, and find the information they need at every stage of their proton therapy journey.

view campus

ProteusONE

The compact proton therapy system transforming cancer treatment

Proton therapy is the most advanced radiotherapy treatment in existence, delivered using the most powerful medical device. By harnessing the specific physical characteristics of protons, proton therapy minimizes radiation exposure to healthy surrounding tissues, potentially leading to fewer side effects than traditional radiotherapy.

References

1.    Nie M, Chen L, Zhang J, Qiu X. Pure proton therapy for skull base chordomas and chondrosarcomas: A systematic review of clinical experience. Front Oncol [Internet]. 2022;12.
2.    Jones B, McMahon SJ, Prise KM. The radiobiology of proton therapy: Challenges and opportunities around relative biological effectiveness. Clin Oncol (R Coll Radiol) [Internet]. 2018;30(5):285–92.
3.    Mohan, Radhe, and David Grosshans. Proton Therapy – Present and Future. Advanced drug delivery reviews 109 (2017): 26–44. Web.
4.    Suit HD. Protons to replace photons in external beam radiation therapy? Clin Oncol (R Coll Radiol) [Internet]. 2003;15(1):S29–31.
5.    Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst [Internet]. 1992;84(3):155–64.
6.    LaRiviere MJ, Santos PMG, Hill-Kayser CE, Metz JM. Proton therapy. Hematol Oncol Clin North Am [Internet]. 2019;33(6):989–1009.
7.    Health Council of the Netherlands. Proton radiotherapy | Advisory report | The Health Council of the Netherlands. Accessed September 16, 2022. https://www.healthcouncil.nl/documents/advisory-reports/2009/12/11/proton-radiotherapy
8.    Glimelius, Bengt et al. Number of Patients Potentially Eligible for Proton Therapy. Acta oncologica 44.8 (2005): 836–849. Web.
9.    Orecchia R, Krengli M. Number of potential patients to be treated with proton therapy in Italy. Tumori [Internet]. 1998 [cited 2024 Apr 28];84(2):205–8.
10.    DeLaney TF. Proton therapy in the clinic. In: IMRT, IGRT, SBRT. S. Karger AG; 2011. p. 465–85.
11.    Ioakeim-Ioannidou M, Rose M, Chen Y-L, MacDonald SM. The use of proton and carbon ion radiation therapy for sarcomas. Semin Radiat Oncol [Internet]. 2024;34(2):207–17.
 

12.    Lomax AJ, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercier P-A, et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol [Internet]. 1999;51(3):257–71.
13.    Sharma, Sonam et al. Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer. International journal of particle therapy 5.2 (2018): 11–17. Web.
14.    Yock, Torunn I et al. Quality of Life Outcomes in Proton and Photon Treated Pediatric Brain Tumor Survivors. Radiotherapy and oncology 113.1 (2014): 89–94. Web.
15.    Laack, N.N. et al. Patient-Reported Quality of Life during Photon and Proton Radiation Therapy: Results of a Prospective Registry of Patient Reported Outcomes in a Large-Volume, Multi-Site Practice. International journal of radiation oncology, biology, physics 102.3 (2018): e739–e739. Web.
16.    Xiang M, Chang DT, Pollom EL. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer. 2020: 126: 3560-3568. https://doi.org/10.1002/cncr.32938
17.    Eaton, Bree R. et al. Secondary Malignancy Risk Following Proton Radiation Therapy. Frontiers in oncology 5 (2015): 261–261. Web.
18.    Chung, Christine S et al. Incidence of Second Malignancies among Patients Treated with Proton versus Photon Radiation. International journal of radiation oncology, biology, physics 87.1 (2013): 46-. Web.
19.    Lee, Anna et al. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma. JAMA network open 6.1 (2023): e2250607-. Web.
20.    Scartoni, Daniele et al. Proton Therapy Re-Irradiation Preserves Health-Related Quality of Life in Large Recurrent Glioblastoma. Journal of cancer research and clinical oncology 146.6 (2020): 1615–1622. Web.
21.    Verma, Vivek et al. Systematic Assessment of Clinical Outcomes and Toxicities of Proton Radiotherapy for Reirradiation. Radiotherapy and oncology 125.1 (2017): 21–30. Web.
22.    Thomas H, Timmermann B. Paediatric proton therapy. Br J Radiol [Internet]. 2020 [cited 2024 May 4];93(1107):20190601.

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Cookies policies